NSIM
JAZZ icon

North Star Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

North Star Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-280
Closed -$28K – 1004
2020
Q1 		$28K Buy
+280
New +$36.2K ﹤0.01% 584
2017
Q4 		– Sell
-100
Closed -$15K – 1085
2017
Q3 		$15K Hold
100
– – ﹤0.01% 766
2017
Q2 		$16K Hold
100
– – ﹤0.01% 741
2017
Q1 		$15K Hold
100
– – ﹤0.01% 736
2016
Q4 		$11K Buy
+100
New +$11.1K ﹤0.01% 735

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

North Star Investment Management's JAZZ Position: Q2 2020 in Review

North Star Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 280 shares — an estimated $28K sold.

North Star Investment Management first reported a position in JAZZ in Q4 2016 and held it in 5 quarters. The position peaked at $28K in Q1 2020. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • North Star Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • North Star Investment Management sold 280 Jazz Pharmaceuticals shares in Q2 2020, an estimated $28K.
  • North Star Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2016 and held it in 5 quarters.
  • North Star Investment Management's Jazz Pharmaceuticals position peaked at $28K in Q1 2020.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on North Star Investment Management's 13F filing for Q2 2020, filed 16 Jul 2020.